# Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

> **NCT01600274** · NA · COMPLETED · sponsor: **Pharbil Waltrop GmbH** · enrollment: 20 (actual)

## Conditions studied

- Focus: Bioequivalence

## Interventions

- **DRUG:** Dienogest-Ethinyl Estradiol (test product)
- **DRUG:** Dienogest-Ethinyl Estradiol (reference product)

## Key facts

- **NCT ID:** NCT01600274
- **Lead sponsor:** Pharbil Waltrop GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01600274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01600274, "Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01600274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*